# Efficacy of EXPAREL vs. Bupivacaine

> **NCT07212114** · PHASE3 · RECRUITING · sponsor: **Emory University** · enrollment: 104 (estimated)

## Conditions studied

- Total Ankle Arthroplasty
- Postsurgical Analgesia

## Interventions

- **DRUG:** EXPAREL
- **DRUG:** 0.25% bupivacaine (HCl): 50 ml
- **DRUG:** 0.25% bupivacaine (HCl): 30 ml

## Key facts

- **NCT ID:** NCT07212114
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-17
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212114, "Efficacy of EXPAREL vs. Bupivacaine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07212114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*